Excited to share our new @JACCJournals paper!
Among 8.4M US adults with prior MI, we found major secondary prevention gaps : ~1/2 met BP or A1c targets, <1/3 met LDL-C <70, and ~1/6 met LDL-C <55.
⭐team: #PeterLibby@Gong2Jingyi@DLBHATTMD@rkwadhera 🔗https://t.co/TjcJU1Fkpd
What an honor to give Cardiology Grand Rounds @nyulangone on why policy may be one of the most powerful cardiovascular interventions we have - and why we should hold it to the same evidence as the drugs we prescribe
Thanks to @SVRaoMD@glennfishman@adambermanmd for having me!
Can AI transform clinical trials?
Published in @CircAHA, our team tested whether locally deployed, open-source LLMs could adjudicate heart failure hospitalizations.
The result: 96.8% accuracy
https://t.co/CmtnBKfras
The role of CHIP in CVD has evolved from a biological curiosity to causally established contributor.
No targeted therapies yet, but risk stratif., prevention, precision medicine, all being reshaped.
The clinical era is coming. We are building it.
@tavrkapadia@CleClinicHVTI
What a week at #ARM26. So proud of the Health Policy Section @SmithBIDMC
Medicaid, SNAP, the IRA, Medicare Advantage, maternal health, and more. Rigorous, timely work from an incredible team.
Until next year 👇
Incredibly proud of this team — presenting across 4 days on Medicaid, SNAP, prescription drug costs under the IRA, Medicare Advantage, maternal health and more. The policy questions couldn't be more timely. @SmithBIDMC
Come find us at Academy Health #ARM26!
Deeply grateful to be elected into the American Society for Clinical Investigation (ASCI) — a reflection of the extraordinary group of trainees and colleagues @SmithBIDMC and beyond. @the_asci
Bleeding remains the last frontier of hemocompatibility in durable LVAD support and RAASi can address it.
Thrilled to have presented this work at #ESCHeartFailure2026 Late-Breaking Science.
Simultaneously published in @EurHeartJ - https://t.co/yzLrIjbfdV
🧵Thread 👇
Congratulations @rkwadhera on your induction into @the_asci, in recognition of his exceptional contributions to cardiovascular and health policy research!
Read more here: https://t.co/HEJAlYMA49
Congratulations @rkwadhera on your induction into @the_asci, in recognition of his exceptional contributions to cardiovascular and health policy research!
Read more here: https://t.co/HEJAlYMA49
New study in @JACCJournals. Among US adults with a prior heart attack, only:
• 1 in 2 meet BP targets
• 1 in 2 meet HbA1c targets
• 1 in 3 meet LDL targets — only 1 in 7 meet the new <55 mg/dL threshold
Secondary prevention in the US remains very poor
https://t.co/NY6ByBJnDv
Excited to share our new @JACCJournals paper!
Among 8.4M US adults with prior MI, we found major secondary prevention gaps : ~1/2 met BP or A1c targets, <1/3 met LDL-C <70, and ~1/6 met LDL-C <55.
⭐team: #PeterLibby@Gong2Jingyi@DLBHATTMD@rkwadhera 🔗https://t.co/TjcJU1Fkpd
The brilliant ⭐️David Morrow delivering @MassGenBrigham HVI Grand Rounds on history and evolving role of CICU, training pathways, research challenges, and opportunities for improving care.
High intensity staffing model --> better outcomes!